Symetryx Corp
Company, not a person
Files as insider at NeuBase Therapeutics, Inc. (NBSE) since August 2023
Symetryx Corp is a company, not a person, and it has filed 6 insider reports with the SEC since September 2023, as insider at NeuBase Therapeutics, Inc. (NBSE). Symetryx Corp made no open-market purchases or sales in the last 12 months. The latest filing, on September 21, 2023, reports other acquisition or disposition at NeuBase Therapeutics, Inc. (NBSE).
- Filings
- 6
- Companies
- 1
- Bought on market
- $59.7K
- Sold on market
- $712K
Companies where Symetryx Corp is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Insidersince August 2023 | 192,481 | $59.7K | $712K | $0.98 | Sep 21, 2023 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Sep 18, 2023NBSESEC Form 5: Symetryx Corp disposed of 0 sharesForm 5Other acquisition or disposition
- Sep 18, 2023-$376KNBSESEC Form 4: Symetryx Corp sold $375,620 worth of shares (282,445 units at $1.33), closing all direct ownership in the companyForm 4Open-market sale
- Aug 23, 2023NBSESEC Form 3: New insider Symetryx Corp claimed ownership of 190,481 shares (Amendment)Form 3New insider
- Sep 11, 2023-$337KNBSESEC Form 4: Symetryx Corp sold $336,731 worth of shares (207,075 units at $1.63), decreasing direct ownership by 30% to 472,926 unitsForm 4Open-market sale
- Sep 1, 2023+$59.7KNBSESEC Form 4: Symetryx Corp bought $59,732 worth of shares (61,076 units at $0.98), increasing direct ownership by 10% to 680,081 unitsForm 4Open-market purchase
- Aug 23, 2023NBSESEC Form 3: New insider Symetryx Corp claimed ownership of 618,925 sharesForm 3New insider
Questions about Symetryx Corp
- How many shares does Symetryx Corp own?
- After the latest filing that states it, Symetryx Corp directly owned 192,481 shares of NeuBase Therapeutics, Inc. (NBSE). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Symetryx Corp bought or sold stock recently?
- The most recent open-market purchase was on September 1, 2023: bought 61,076 shares of NeuBase Therapeutics, Inc. (NBSE) for $59.7K at an average of $0.98. The most recent open-market sale was on September 18, 2023: sold 282,445 shares of NeuBase Therapeutics, Inc. (NBSE) for $376K at an average of $1.33.
- How do I get alerts when Symetryx Corp files?
- Follow Symetryx Corp on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Symetryx Corp (SEC CIK 0001991925). Totals count each trade once, skipping amendments whose original is on file, from Sep 1, 2023 on. View on SEC EDGAR